These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8995509)

  • 1. Influence of route of administration on [3H]-camptothecin distribution and tumor uptake in CASE-bearing nude mice: whole-body autoradiographic studies.
    Ahmed AE; Jacob S; Giovanella BC; Kozielski AJ; Stehlin JS; Liehr JG
    Cancer Chemother Pharmacol; 1996; 39(1-2):122-30. PubMed ID: 8995509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative disposition of the antineoplastic agent 9-nitrocampotothecin and the inactive isomer 12-nitro camptothecin in CASE-bearing nude mice: effect of route of administration on tissue distribution.
    Ahmed AE; Jacob S; Giovanella BC; Kozielski AJ; Liehr JG; Stehlin JS
    Cancer Chemother Pharmacol; 1997; 41(1):29-36. PubMed ID: 9443611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of camptothecins administered orally.
    Liehr JG; Ahmed AE; Giovanella BC
    Ann N Y Acad Sci; 1996 Dec; 803():157-63. PubMed ID: 8993508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer-bound camptothecin: initial biodistribution and antitumour activity studies.
    Caiolfa VR; Zamai M; Fiorino A; Frigerio E; Pellizzoni C; d'Argy R; Ghiglieri A; Castelli MG; Farao M; Pesenti E; Gigli M; Angelucci F; Suarato A
    J Control Release; 2000 Mar; 65(1-2):105-19. PubMed ID: 10699275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of camptothecin after delivery as a liposome aerosol or following intramuscular injection in mice.
    Koshkina NV; Gilbert BE; Waldrep JC; Seryshev A; Knight V
    Cancer Chemother Pharmacol; 1999; 44(3):187-92. PubMed ID: 10453719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker.
    Conover CD; Greenwald RB; Pendri A; Gilbert CW; Shum KL
    Cancer Chemother Pharmacol; 1998; 42(5):407-14. PubMed ID: 9771956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral versus intraperitoneal administration of irinotecan in the treatment of human neuroblastoma in nude mice.
    Choi SH; Tsuchida Y; Yang HW
    Cancer Lett; 1998 Feb; 124(1):15-21. PubMed ID: 9500186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the pharmacokinetics and efficacy of irinotecan after administration by the intravenous versus intraperitoneal route in mice.
    Guichard S; Chatelut E; Lochon I; Bugat R; Mahjoubi M; Canal P
    Cancer Chemother Pharmacol; 1998; 42(2):165-70. PubMed ID: 9654118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and tissue distribution of irinotecan hydrochloride nanoparticles].
    Yang FY; Zhang WP; Chen HL; Fu Y; Wang XY; Wei SJ; Yang XY; Zhang YX; Dang HW
    Yao Xue Xue Bao; 2013 Jun; 48(6):940-5. PubMed ID: 23984532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patients.
    Slatter JG; Schaaf LJ; Sams JP; Feenstra KL; Johnson MG; Bombardt PA; Cathcart KS; Verburg MT; Pearson LK; Compton LD; Miller LL; Baker DS; Pesheck CV; Lord RS
    Drug Metab Dispos; 2000 Apr; 28(4):423-33. PubMed ID: 10725311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice.
    Schluep T; Cheng J; Khin KT; Davis ME
    Cancer Chemother Pharmacol; 2006 May; 57(5):654-62. PubMed ID: 16133526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice.
    Kawato Y; Furuta T; Aonuma M; Yasuoka M; Yokokura T; Matsumoto K
    Cancer Chemother Pharmacol; 1991; 28(3):192-8. PubMed ID: 1855276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarrier improves the bioavailability, stability and antitumor activity of camptothecin.
    Tang XJ; Han M; Yang B; Shen YQ; He ZG; Xu DH; Gao JQ
    Int J Pharm; 2014 Dec; 477(1-2):536-45. PubMed ID: 25445532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of SN-38 [(+)-(4S)-4,11-diethyl-4,9-dihydroxy-1H- pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4H,12H)-dione], an active metabolite of irinotecan, after a single intravenous dosing of 14C-SN-38 to rats.
    Atsumi R; Okazaki O; Hakusui H
    Biol Pharm Bull; 1995 Aug; 18(8):1114-9. PubMed ID: 8535406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles.
    Kawano K; Watanabe M; Yamamoto T; Yokoyama M; Opanasopit P; Okano T; Maitani Y
    J Control Release; 2006 May; 112(3):329-32. PubMed ID: 16678929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy.
    Zhang F; Zhu G; Jacobson O; Liu Y; Chen K; Yu G; Ni Q; Fan J; Yang Z; Xu F; Fu X; Wang Z; Ma Y; Niu G; Zhao X; Chen X
    ACS Nano; 2017 Sep; 11(9):8838-8848. PubMed ID: 28858467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic characteristics of the novel anticancer agent CPT-11 and its active metabolite in plasma and lung lymph fluid following intravenous administration to sheep.
    Koizumi T; Kubo K; Hanaoka M; Miyahara T; Kaneki T; Yamamoto H; Ge RL; Fujimoto K; Kobayashi T; Sekiguchi M
    Arzneimittelforschung; 1998 Nov; 48(11):1097-100. PubMed ID: 9850432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor.
    Li C; Newman RA; Wu QP; Ke S; Chen W; Hutto T; Kan Z; Brannan MD; Charnsangavej C; Wallace S
    Cancer Chemother Pharmacol; 2000; 46(5):416-22. PubMed ID: 11127947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced lactone stability of CZ48 in blood correlates to its lack of toxicity in mice.
    Liu X; Wang Y; Cao Z; Zhan M; Vardeman D; Giovanella B
    J Pharm Pharm Sci; 2013; 16(1):115-24. PubMed ID: 23683610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.